{"id":7051,"date":"2015-01-09T12:16:39","date_gmt":"2015-01-09T11:16:39","guid":{"rendered":"http:\/\/www.fedaiisf.it\/?p=7051"},"modified":"2015-01-09T12:57:21","modified_gmt":"2015-01-09T11:57:21","slug":"ritiro-augmentin-dimportazione-federconsumatori-nessun-avviso-consumatori","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/ritiro-augmentin-dimportazione-federconsumatori-nessun-avviso-consumatori\/","title":{"rendered":"Withdrawal Imported Augmentin. Federconsumatori: no notice to consumers"},"content":{"rendered":"

The news was known and we have it published on 12\/12\/2014<\/a> along with other \u201cdefective\u201d drugs. Some batches of medicines Torastin and Furosemide Salf and ADESITRIN 15 mg\/24 h transdermic patches have also been withdrawn.<\/em><\/p>\n

Friday, 09 January 2015 \u2013 Pharmacist33<\/a><\/i><\/p>\n

\"\"The Italian Medicines Agency (Aifa) has ordered the withdrawal of the batches of the antibiotic drug Augmentin<\/a> 12 coated tablets 875+125 mg, coming from "parallel import" with indications in the package leaflet and internal labels in Romanian.<\/p>\n

The information reached pharmacies and distributors, but the Federconsumatori association writes in a note, "the citizens were not warned". And he adds: \u00abIn the face of irregularities in the production of widely consumed drugs, it is surprising that we have only recently come to know of a provision dated 5 December 2014 which forced purchases to be halted but did not give patients indications not to use the drug from Romania".<\/p>\n

The Aifa note indicates that the withdrawal concerns Aip lots no. 039785047 with internal labels in Romanian and "was arranged following reports from the companies GlaxoSmithKline and Medifarm". According to Federconsumatori \u00abthe alarm that forced pharmacies to block the sale and use of the well-known antibiotic has inexplicably ignored citizens.<\/p>\n

Those who bought the suspect products before the withdrawal were not informed at all about the risks of using them.' And he adds: \u00abThe question arises spontaneously: why were the citizens not warned? Why weren't they asked to check the product packaging in their possession? It is necessary to clarify and reaffirm the maximum commitment to avoid exposing citizens to health risks".
\nSimone Zazzetta<\/i><\/p>\n

Ed<\/i><\/b>.: the news was known and the more attentive readers of this site will in fact remember that we published it on 12 December 2014 in the article Defective medicines withdrawn<\/a><\/i><\/p>\n

Related news: FOFI release<\/a><\/p>\n

Aifa orders the withdrawal of some lots of medicines Torastin and Furosemide Salf<\/span><\/h2>\n

\"\"The measure concerns Torastin 10 mg and 20 mg film-coated tablets 30 tablets. Furosemide Salf was withdrawn following reports concerning difficulties in opening the vials with cases of breakage in the hands of the operator.<\/p>\n

08 JAN \u2013 The Pharmacist<\/a> \u2013 Aifa has sent a provision ordering the withdrawal of:<\/p>\n

\u2212 TORASTIN 10 mg film-coated tablets 30 tablets, AIC 040129049\/M, lots no. C305065, C309103, C404781, Farmaceutici Caber SpA;<\/p>\n

\u2212 TORASTIN 20 mg film-coated tablets 30 tablets, AIC 040129102\/M, lots no. C305066, C309104, C404782, Farmaceutici Caber SpA;<\/p>\n

\u2212 TORASTIN 40 mg film-coated tablets 30 tablets, AIC 040129153\/M, lots no. C303411, C401798, Farmaceutici Caber SpA. The drugs were withdrawn following the company's report concerning possible out-of-specification results.<\/p>\n

\u2212 FUROSEMIDE SALF 5 vials 20 mg\/2ml, lot no. A4G051, company SALF Laboratorio Farmacologico SpA. The drug was withdrawn following reports concerning difficulties in opening the vials with cases of breakage of the same in the hands of the operator.<\/p>\n

Pending collection, the lots in question cannot be used.<\/p>\n

08 January 2015<\/p>\n

THE FOFI MEASURE<\/a><\/p>\n\n\n\n\n\n
\n

Aifa orders withdrawal of medicinal lots "ADESITRIN 15 mg\/24 h transdermic patches"<\/span><\/h2>\n<\/td>\n<\/tr>\n

<\/td>\n<\/tr>\n
The\u00a0measure\u00a0<\/a>it was released following a report from the company, Pfizer, concerning out-of-specification results during stability studies performed on the drug.<\/i><\/b><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

\"\"31 DEC \u2013 AIFA has ordered the withdrawal of some lots of the medicine \u201cADESITRIN 15 mg\/24 h transdermal patches\u201d, AIC n. 026068039 of the Pfizer company, following the report from the company, concerning out-of-specification results during stability studies carried out on the drug.<\/p>\n

December 31, 2014 \u2013 The Pharmacist<\/a><\/p>\n

THE AIFA PROVISION<\/a><\/p>","protected":false},"excerpt":{"rendered":"

La notizia era nota e l’abbiamo pubblicata il 12\/12\/2014 insieme ad altri farmaci “difettosi”. Ritirati anche\u00a0alcuni lotti di medicinali Torastin e Furosemide Salf e\u00a0ADESITRIN 15 mg\/24 h cerotti transdermic. Venerd\u00ec, 09 Gennaio 2015 \u2013 Farmacista33 L’Agenzia italiana del farmaco (Aifa) ha disposto il ritiro dei lotti del farmaco antibiotico Augmentin 12 compresse rivestite 875+125 mg, …<\/p>","protected":false},"author":4,"featured_media":7058,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[49],"class_list":["post-7051","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-notizie","tag-aifa"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/7051","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=7051"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/7051\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/7058"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=7051"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=7051"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=7051"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}